PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 16 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $149,000 | +39.3% | 32,443 | 0.0% | 0.00% | – |
| Q1 2020 | $107,000 | -60.1% | 32,443 | -26.0% | 0.00% | – |
| Q4 2019 | $268,000 | +63.4% | 43,843 | +11.4% | 0.00% | – |
| Q3 2019 | $164,000 | -69.0% | 39,343 | -2.5% | 0.00% | -100.0% |
| Q2 2019 | $529,000 | +75.2% | 40,343 | +26.9% | 0.00% | – |
| Q1 2019 | $302,000 | +214.6% | 31,788 | +1.9% | 0.00% | – |
| Q4 2018 | $96,000 | – | 31,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|